A case of progressive mucinous ovarian cancer of low malignant potential responsive to biologic therapy with Bevacizumab

Gynecol Oncol. 2010 Mar;116(3):578-9. doi: 10.1016/j.ygyno.2009.10.068. Epub 2009 Nov 8.

Authors

Ira Winer¹, Ronald J Buckanovich

Affiliation

¹ Department of Obstetrics and Gynecology, University of Michigan, Rm 5219 Cancer Center, Ann Arbor, MI 48109, USA.

PMID: 19897232
DOI: 10.1016/j.ygyno.2009.10.068

No abstract available

Publication types

Case Reports

MeSH terms

Adenocarcinoma, Mucinous / blood supply
Adenocarcinoma, Mucinous / drug therapy*
Adenocarcinoma, Mucinous / pathology
Adult
Angiogenesis Inhibitors / therapeutic use*
Antibodies, Monoclonal / therapeutic use*
Antibodies, Monoclonal, Humanized
Bevacizumab
Female
Humans
Ovarian Neoplasms / blood supply
Ovarian Neoplasms / drug therapy*
Ovarian Neoplasms / pathology

Substances

Angiogenesis Inhibitors
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Bevacizumab